| | | | Index Performance | | Index | Sensex | Nifty | | Open | 13,481.85 | 4,108.75 | | High | 13,486.20 | 4,110.70 | | Low | 13,054.42 | 3,970.35 | | Today's Cls | 13,102.18 | 3,985.25 | | Prev Cls | 13,547.18 | 4,110.55 | | Change | -445.00 | -125.30 | | % Change | -3.28 | -3.05 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Tata Comm | 466.10 | 4.67 | | Colgate Palmolive | 405.60 | 2.41 | | Dabur India | 89.05 | 2.30 | | ITC | 192.25 | 2.04 | | Glenmark Pharma | 570.40 | 1.81 | | Losers | | Akruti city | 799.60 | -16.74 | | Gujarat Petronet | 45.95 | -11.38 | | Gujarat NRE | 58.95 | -9.66 | | Aban Offshore | 2,099.85 | -9.63 | | Century Textiles | 344.00 | -9.30 | | | Market Statistics | | - | BSE | NSE | | Advances | 442 | 184 | | Declines | 2,172 | 1,331 | | Unchanged | 59 | 21 | | Volume(Nos) | 25.14cr | 43.23cr | | | | | | Market Commentary | | | Selling spree continues | | Unabated across-the-board selling saw the Sensex shed 445 points and close just above the 13100 level. | | The bear hammering continued unabated in the market, with the index crashing below the 13,000 level amid weakness in global indices,slump in the | 
| | | overseas commodities markets and continuing exodus of foreign institutional investment (FII) money from the domestic markets. Keeping with its southward journey, the Sensex started the day with a negative gap of 65 points at 13,482 and shed another 428 points to slip below the 13,000 level in the early trades to touch the day's low of 13,054. The market however moved above 13,200 for the better part of the session with a negative bias. Sustained selling pressure towards the close saw the Sensex slump below 13,100 and end 3.28% or 445 points lower at 13,102, while Nifty dropped 125 points at 3,985. | |
The breadth of the market was extremely negative. Of the 2,673 stocks traded on the BSE, 2,169 stocks declined, while only 445 stocks advance. 59 stocks remained unchanged. Among the sectoral indices, the BSE FMCG ended positive while other indices fell around 0.96% each. The BSE Realty was the major loser and crumbled by 6.33% followed by BSE Metal (down 4.76%), BSE Bankex (down 4.27%), BSE CG (down 4.10%), BSE Power (down 3.47%) and BSE IT (down 3.39%).
Barring State Bank of India, ITC, Hindustan Unilever and ACC, the remaining 27 Sensex stocks ended in a negative territory. Sliding sharply Ranbaxy Laboratories crumbled by 8.04% at Rs272.40, Sterlite industries plunged 6.28% at Rs447.20, ICICI Bank dropped 5.83% at Rs561.25, Grasim Industries slumped by 5.72% at Rs1760.50, Hindalco declined by 5.17% at Rs99.10, Mahindra & Mahindra shed 5.06% at Rs530.50, BHEL fell by 5.03% at Rs1538.20 and DLF lost 5.01% at Rs369.50. Other front-line stocks also bore the brunt of the selling pressure and declined around 2-3% each.
Over 96.73 lakh shares of IFCI changed hands on the BSE followed by Reliance Natural Resources (87 lakh shares), Anant Raj Industries (85 lakh shares), Sesa Goa (82 lakh shares) and Idea Cellular (65 lakh shares).
| | | | | | | | European Indices at 16:15 IST on 26-09-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 5096.01 | -101.01 | -1.94 | | CAC 40 Index | 4141.81 | -85.00 | -2.01 | | DAX Index | 6046.43 | -126.6 | -2.05 | | | | | | | | | | | Asian Indices at close on 26-09-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 11,893.16 | -113.37 | -0.94 | | Hang Seng Index | 18,682.09 | -252.34 | -1.33 | | Kospi Index | 1476.33 | -25.30 | -1.68 | | Straits Times Index | 2411.46 | -32.78 | -1.34 | | Jakarta Composite Index | 1846.90 | -23.97 | -1.28 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
